Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...